Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/336938
Title: Effect of PGI2 Analogue ONO 1301 Incorporated Nanocomposite Fibrous Scaffold on Bone Regeneration
Researcher: Shruthy Kuttappan
Guide(s): Manitha B Nair
Keywords: Cyclooxygenase; endochondral; Orthopedics bones;Autografts; Prostaglandins; Spectroscopy; Histomorphometric; Cytotoxicity; mesenchymal stem cells; bone regeneration; hydroxyapatite; Prostacyclin analogue; ONO-1301; Composite scaffolds; Biomimetic; Collagen; Gelatin; Morphogenetic; morphogenetic protein 2 (BMP2).
University: Amrita Vishwa Vidyapeetham University
Completed Date: 2020
Abstract: The restoration of bone defects occurring as a consequence of trauma or pathologic conditions is a substantial clinical problem that needs the support of bone-graft to attain union. Biomaterials such as ceramics or composites proved to be osteoconductive and osteointegrative as its chemical composition matches native bone. However, they lack osteoinductive and vascularisation potential and fail to regenerate bone in critical sized defects. Bone fracture healing is a multifaceted event governed by mesenchymal stem cells (MSCs), endothelial cells etc and its secretary factors like vascular endothelial growth factor (VEGF), bone morphogenetic protein 2 (BMP2) and fibroblast growth factor (FGF2). However, high manufacturing cost and protein instability are the common limitations associated with growth factor-based therapeutic strategies. In contrast, small molecules are stable biofactors that are available at cheaper rate and can be produced in reproducible quality. Hence small molecules with angiogenic and osteogenic properties could be considered as next-generation biofactors for orthopaedic therapeutics. newlineProstaglandins are small molecules that are enzymatically derived from arachidonic acid that are known to play important roles in bone formation and metabolism. ONO-1301 is a small molecular weight prostacyclin analogue that can augment angiogenesis. In addition, it stimulate the expression of stromal cell-derived factor-1 (SDF-1), resulting in enhanced migration of circulating bone marrow-derived stromal cells. There is one report that demonstrated that ONO-1301 can enhance bone regeneration in ectopic and orthotopic model when used in combination with BMP2. Nevertheless, this study did not show the mechanism of action of ONO-1301 on osteoblast cells and bone formation. Since bone repair is a complex process, it is important to understand the mechanism through which ONO-1301 act on bone tissue regeneration (chemotactic or angiogenic or osteoinductive role). Moreover, this study did not show the local..
Pagination: xii, 111
URI: http://hdl.handle.net/10603/336938
Appears in Departments:Amrita Centre for Nanosciences and Molecular Medicine

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File409.95 kBAdobe PDFView/Open
02_declaration.pdf487.36 kBAdobe PDFView/Open
03_certificate.pdf510.51 kBAdobe PDFView/Open
04_contents.pdf331.81 kBAdobe PDFView/Open
05_acknowledgement.pdf300.36 kBAdobe PDFView/Open
06_abstract.pdf324.96 kBAdobe PDFView/Open
07_abbreviation.pdf327.95 kBAdobe PDFView/Open
08_notation.pdf316.44 kBAdobe PDFView/Open
09_list of figure.pdf337.46 kBAdobe PDFView/Open
10_list of tables.pdf195.61 kBAdobe PDFView/Open
11_chapter 1.pdf1.32 MBAdobe PDFView/Open
12_chapter 2.pdf937.98 kBAdobe PDFView/Open
13_chapter 3.pdf6.64 MBAdobe PDFView/Open
14_chapter 4.pdf629.61 kBAdobe PDFView/Open
15_references.pdf796.72 kBAdobe PDFView/Open
16_publications.pdf534.36 kBAdobe PDFView/Open
80_recommendation.pdf1.04 MBAdobe PDFView/Open
Show full item record


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: